MTHFR and colorectal cancer: Despite these theoretical and experimental premises, clinical studies which have evaluated the effect of TYMS (Gusella and Padrini, 2007) and MTHFR (Robien et al, 2005) polymorphisms on the colorectal cancer response/toxicity to 5FU have produced inconsistent results.